Thursday announced that it has secured a new U.S. patent for its innovative Phase Change Composite spacer product ...
Beam Therapeutics (BEAM) announced the company will encore data from the BEACON Phase 1/2 clinical trial of BEAM-101 in sickle cell disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback